Purpose The aim of this study was to quantify the initial decline and subsequent rebound in
breast cancer screening metrics throughout the coronavirus disease 2019 (COVID-19) …

Starting in Wuhan, China, followed quickly in the United States in January 2020, an outbreak
of a novel coronavirus, or COVID-19, escalated to a global pandemic by March. Significant …

Purpose In order to facilitate targeted outreach, we sought to identify patient populations with
a lower likelihood of returning for breast cancer screening after COVID-19-related imaging …

BACKGROUND To understand how health care delays may affect breast cancer detection,
the authors quantified changes in breast‐related preventive and diagnostic care during the …

Background The COVID-19 pandemic reduced mammography use, potentially delaying
breast cancer diagnoses. Purpose To examine breast biopsy recommendations and breast …

The COVID-19 pandemic disrupted breast cancer screening and diagnostic imaging in the
United States. We sought to evaluate how medical facilities prioritized breast imaging …

Background The coronavirus disease 2019 (COVID-19) pandemic led to a near-total
cessation of mammography services in the United States in mid-March 2020. It is unclear if …

During the COVID-19 pandemic, breast imaging must be performed using safe practices.
Balancing the need to avoid delays in the diagnosis of breast cancer while avoiding …

Background Breast cancer care has been affected by the COVID-19 pandemic. This
systematic review aims to describe the observed pandemic-related changes in clinical and …

Background The objective of the current study was to provide insight into the effect of
coronavirus disease 2019 (COVID‐19) on breast cancer screening, breast surgery, and …